Mark G. Kris, MD

Medical Oncologist

William and Joy Ruane Chair in Thoracic Oncology

Conditions Treated:

Pictured: Mark Kris

About Me

I am a medical oncologist who specializes in the care of people with cancers arising in the lungs.  In my research, I aim to discover better treatments for individuals with lung cancers by studying the genetic characteristics of their tumors. I lead a research team working to find new genetic targets in cancer cells, and to test anticancer medicines that specifically attack the lung cancers driven by these molecular changes.  I work with surgeons and radiation specialists to find the best ways to use surgery, radiotherapy, and drugs together to increase the chance of cure.

Read more

I also lead Memorial Sloan Kettering’s project to train IBM’s Watson supercomputer to collect and interpret information about both the person and their cancer to help in selecting the best treatments.

In my practice, I work with two special nurses. Together we strive to fight cancer and to minimize the physical symptoms of cancer so everyone under our care can spend their lives doing what matter most to them.

  • Clinical Expertise: Lung Cancer; New Cancer Treatments; Thymoma; Mediastinal Tumors; Control of Side Effects and Physical Problems Caused by Cancer and Cancer Treatments
  • Languages Spoken: English
  • Education: MD, Cornell University Medical College
  • Residencies: The New York Hospital-Cornell Medical Center; Memorial Sloan Kettering Cancer Center
  • Fellowships: Memorial Sloan Kettering Cancer Center
  • Board Certifications: Internal Medicine; Medical Oncology

Appointments Available

Making an appointment

Call 866-MSK-LUNG

See My Colleagues

Publications

Visit PubMed for a full listing of Mark G. Kris’ journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.